PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8624317-8	1996	RESULTS: The baseline levels of IGFBP-1 were normal but PP14 could only be detected in one third of the patients, which was due, in part, to pre-operative treatment with danazol.	Danazol	170-177	progestagen associated endometrial protein	Homo sapiens	56-60	
2801831-8	1989	Treatment with danazol (600 mg/day), or with medroxyprogesterone acetate (100 mg/day) after laparoscopy also resulted in significant decreases in the serum PP14 concentration.	Danazol	15-22	progestagen associated endometrial protein	Homo sapiens	156-160	
2801831-9	1989	After 6 months of treatment, conservative surgery in combination with danazol or with medroxyprogesterone acetate, yielded more pronounced declines in serum PP14 level than conservative surgery plus placebo.	Danazol	70-77	progestagen associated endometrial protein	Homo sapiens	157-161	
2801831-11	1989	We conclude that endometriosis tissue contributes to the circulating PP14 level, and the decline in PP14 level during danazol and medroxyprogesterone acetate treatments reflects regression of intrauterine and ectopic endometrial tissues.	Danazol	118-125	progestagen associated endometrial protein	Homo sapiens	100-104	
3680485-3	1987	The serum progesterone concentration decreased significantly during Danazol treatment, as did the serum levels of 34K IGF-bp and PP14.	Danazol	68-75	progestagen associated endometrial protein	Homo sapiens	129-133	
3680485-5	1987	In light of the previous observations on the IGF-bp and PP14 synthesis by secretory endometrium and the fact that Danazol causes endometrial atrophy, these results suggest that Danazol treatment has an effect on endometrial protein secretion.	Danazol	177-184	progestagen associated endometrial protein	Homo sapiens	56-60